Open AccessVitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort
Author(s) -
Valory Pavlik,
Rachelle S. Doody,
Susan Rountree,
Eveleen Darby
Publication year - 2009
Publication title -
dementia and geriatric cognitive disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.026
H-Index - 110
eISSN - 1421-9824
pISSN - 1420-8008
DOI - 10.1159/000255105
Subject(s) - medicine , hazard ratio , cohort , proportional hazards model , vitamin e , vitamin , vitamin d and neurology , gastroenterology , confidence interval , antioxidant , biochemistry , chemistry
Vitamin E at a dose of 2,000 IU per day has been shown to delay Alzheimer's disease (AD) progression, but recent studies have questioned the safety of this dose level and the overall efficacy of vitamin E in AD treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom